CN216497618U - Platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation - Google Patents
Platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation Download PDFInfo
- Publication number
- CN216497618U CN216497618U CN202121875783.XU CN202121875783U CN216497618U CN 216497618 U CN216497618 U CN 216497618U CN 202121875783 U CN202121875783 U CN 202121875783U CN 216497618 U CN216497618 U CN 216497618U
- Authority
- CN
- China
- Prior art keywords
- injector
- syringe
- freezing
- blood
- rich plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The utility model relates to the technical field of medical instruments, in particular to a platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation. The plasma produced by the device and method of the present invention is not only pure (without exogenous anticoagulants and other additives) but also has different switchable usage patterns: within 30 minutes at low temperature (above freezing temperature), the separated plasma is in liquid state, and the liquid plasma can be converted into jelly-like gel along with the change of temperature and time, so that different clinical requirements can be met, and the application space is expanded; by using the device and the method disclosed by the utility model, platelet plasma or gel with different concentrations can be prepared by only strictly controlling three factors of temperature, time and centrifugal force.
Description
Technical Field
The utility model relates to the technical field of medical instruments, in particular to a platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation.
Background
The blood of a human body consists of visible components (including red blood cells, white blood cells, and platelets) and a liquid component (blood plasma), and the blood is called whole blood after being isolated, and the whole blood contains a large amount of blood coagulation factors including blood coagulation factor i (fibrinogen), blood coagulation factor ii (prothrombin), blood coagulation factor iii (tissue factor), blood coagulation factor iv (calcium ion), blood coagulation factor v (procoagulant fibrinogen), and the like. Both endogenous and exogenous activation systems exist in the human body. The former refers to cardiovascular intimal damage, or blood outflow from the body activates factor xii by contact with abnormal surfaces. The latter, in turn, activates factor vii by releasing factor iii due to tissue damage. Both initiate a series of chain reactions and converge at factor X, which ultimately leads to activation of prothrombin and formation of fibrin. If the blood coagulation factor is activated, the fibrinogen in the blood is converted into fibrin, the blood is coagulated to separate out serum, if the blood coagulation factor IV (calcium ions) is directly chelated by adopting a blood anticoagulant, the conversion of the fibrinogen can be prevented, the blood is anticoagulated, the anticoagulated blood has formed components deposited under the action of certain centrifugal force, and faint yellow liquid which is called plasma is separated by chromatography. Specifically, the blood contains red blood cells (specific gravity of about 1.093), white blood cells (specific gravity of 1.075 to 1.092) and platelets (specific gravity of about 1.040), the specific gravity of the blood-forming components is greater than that of the liquid-forming component plasma (1.020 to 1.040), the blood-forming components precipitate under the action of centrifugal force, and the platelets having a specific gravity close to that of the plasma are in a colloidal state, and are located at the intersection of the liquid-forming components and the blood-forming components or suspended in the plasma in the lower layer under the appropriate centrifugal force. According to this principle of gradient density separation, a liquid component and a formed component in blood can be separated, and a desired blood component can be obtained by adjusting the rotation speed of a centrifuge, the centrifugal force, the centrifugation time, and other factors.
In modern medical practice, platelet-rich plasma (PRP for short) has been widely used in many fields such as regenerative medicine and medical cosmetology, and most of the methods adopted at present are to add a certain proportion of anticoagulant to whole blood after exsomatization, keep the blood in a fluid state by the action of the anticoagulant, and then separate the formed components from the liquid components of the blood by a centrifugal device. The disadvantage of this method is that an external component, anticoagulant, must be added to chelate calcium ions in the blood, activate platelets, and prevent blood coagulation. In subsequent applications, the originality of the blood has been destroyed due to the addition of anticoagulants, and many active substances in the blood may be inhibited, neutralized or activated, which may have an impact on many medical programs requiring regenerative healing treatment with autologous blood. Especially, in the case of gelatinous fibrin, thrombin and calcium ions are often added to treat plasma, and due to the addition of exogenous thrombin and calcium ions, the plasma is not pure enough, which also affects the use effect.
Chinese patent No. 201810583443.6 relates to a platelet-rich plasma preparation device, and belongs to the field of medical appliances. The utility model provides a platelet-rich plasma preparation device, which comprises: a pipe body and a pressure lever; the top end of the tube body is open and the bottom end is closed; the lower edge of the pressure lever slides along the inner wall of the tube body in a sealing way; the interior of the tube body comprises a first chamber and a second chamber; the pressure lever is a hollow lever, a pressure lever side port is arranged on the side wall of the pressure lever, and the pressure lever side port is communicated with the first cavity and the second cavity.
Chinese patent No. 201611080605.1 relates to a device and a method for rapidly extracting platelet rich plasma, and belongs to the field of platelet rich plasma extraction equipment and methods. The device comprises a centrifuge tube, the centrifuge tube comprises an inner syringe body, an outer syringe body and a sealing cover sleeved on the inner syringe body, the inner syringe body is provided with a contraction channel, after blood is centrifuged, the channel can be closed through a buckle device, so that cell components are prevented from being sucked, the operation process of centrifugation is simplified, and the concentration and preparation efficiency of platelet-rich plasma after centrifugation are improved; meanwhile, the outer injector of the centrifugal tube is in a centrifugal tube shape and can be adapted to general centrifugal equipment on the market, so that the platelet rich plasma enrichment device is simple to operate and low in cost, and a device and a method for platelet rich plasma and platelet rich gel with high concentration and low cost can be provided for clinical research.
In the prior art, in the process of separating the platelet rich plasma, the blood is contained by using a test tube, so that the separation of the platelet rich plasma is inconvenient; anticoagulant is required to be added when the platelet rich plasma is separated, so that the separated platelet rich plasma is not pure enough; in addition, the time for separating the platelet rich plasma is long, which results in the decrease of the efficiency of separating the platelet rich plasma, so that the development of a platelet rich plasma collecting and separating device adopting physical freezing anticoagulation is urgently needed.
Disclosure of Invention
The utility model aims to provide a platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation, which aims to solve the problems of inconvenient separation, impure separated platelet-rich plasma and low separation efficiency in the background technology.
The technical scheme of the utility model is as follows: a platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation comprises an outer injector, wherein an inner injector is inserted into the outer injector, a piston assembly is arranged at the bottom of the inner injector and positioned inside the outer injector, a fixed anti-rotation frame is integrally formed at the top of the piston assembly and positioned between the outer injector and the inner injector, an injector push-pull rod is inserted into the inner injector, a push-pull handle is integrally formed on the outer wall of the top of the injector push-pull rod, an inner piston is connected to the bottom end of the injector push-pull rod through threads, and the inner piston is positioned inside the inner injector;
fixed anti-rotation frame is cavity cover tube column structure, fixed anti-rotation frame marginal portion opens there is the fretwork groove, fixed anti-rotation frame remains two-sided stand, piston assembly's lower extreme is planar structure, open in the middle of the piston assembly has the feed liquor hole, piston assembly's feed liquor hole top integrated into one piece has the connector of external screw thread structure, the bottom outer wall integrated into one piece of interior syringe has interior needle file, connector threaded connection is inside interior needle file, outer syringe and interior syringe are linked together through the feed liquor hole.
Further, an outer needle seat is integrally formed on the outer wall of the bottom of the outer injector, and a freezing sleeve is sleeved outside the outer injector.
Furthermore, the top inner wall integrated into one piece of outer syringe has two archs, two the arch and fretwork groove looks adaptation.
Furthermore, the bottom of outer needle file has cup jointed the shutoff spiral cover, the bottom inner wall integrated into one piece of shutoff spiral cover has the cock stem, cock stem threaded connection is in the inside of outer needle file, cock stem and interior needle file looks adaptation.
Furthermore, freezing sleeve pipe includes outer tube and interior sleeve pipe, be provided with water storage chamber intermediate layer between outer tube and the interior sleeve pipe.
Furthermore, a certain amount of purified water is filled in the interlayer, the inner pipe and the outer pipe are sealed by adopting the modes of ultrasonic welding, adhesive plugging and the like after the purified water is filled in the interlayer, and the low temperature can be kept for a certain time after the interlayer is frozen.
Furthermore, the outer wall of the top of the outer injector is integrally formed with a retaining ring, and the outer wall of the top of the inner injector is integrally formed with a pull ring.
A method for preparing platelet rich plasma by physical freezing anticoagulation specifically comprises the following steps:
s1, placing an inner and outer double-syringe structure into a freezing sleeve, packaging according to the requirement of aseptic packaging, then placing the double syringes together into a 0-20 ℃ freezing chamber for 30 minutes after sterilization treatment, taking out the double syringes, taking another sterilized blood taking needle with a luer connector needle base, taking down a sealing spiral cover of the double syringes, and installing the needle base connector of the blood taking needle on an outer needle base of an outer syringe.
Conventional disinfection, the blood taking needle is used for puncturing the vein, after blood returns, the syringe of the inner syringe is pulled, and the blood flows into the outer syringe; after blood collection is finished, taking down a luer connector needle seat of a blood collection needle, installing a plugging spiral cover on an outer needle seat of an outer injector, putting the double injectors into a freezing sleeve again, putting the freezing sleeve and the freezing sleeve into a horizontal centrifuge, balancing the centrifuge, setting centrifugal force 700G, centrifuging for 8 minutes, taking out the double injectors after centrifugation, pulling a push-pull rod of the injector to suck platelet-rich plasma of a faint yellow liquid part in the outer injector into the inner injector, and completing separation.
S2, placing the inner and outer double-injector structure into a freezing sleeve, packaging according to the aseptic packaging requirement, then placing the double-injector structure into a freezing chamber at 0-20 ℃ for 30 minutes after carrying out sterilization treatment, and taking out the double-injector. Taking another sterilized blood taking needle with a luer connector needle base, taking down the plugging spiral cover of the double syringes, and installing the needle base connector of the blood taking needle on the outer needle base of the outer syringe.
Conventional disinfection, the blood taking needle is used for puncturing the vein, after blood returns, the syringe of the inner syringe is pulled, and the blood flows into the outer syringe; after blood collection is finished, taking down a luer connector needle seat of a blood collection needle, installing a plugging spiral cover on an outer needle seat of an outer syringe, putting a double syringe into a freezing sleeve again, putting the double syringe and the freezing sleeve into a horizontal centrifuge, balancing the double syringe by the centrifuge, setting centrifugal force 700G, centrifuging for 8 minutes, taking out the double syringe after centrifugation, pulling a push-pull rod of the syringe to suck platelet-rich plasma of a faint yellow liquid part in the outer syringe into the inner syringe, taking another plugging spiral cover to seal the needle seat of the inner syringe, putting the needle seat into the freezing sleeve again, putting the double syringe into the horizontal centrifuge again, balancing the centrifuge, setting centrifugal force 500G, centrifuging for 5 minutes, taking out the syringe after centrifugation, wherein the lower section of the syringe close to the needle seat is high-concentration platelet plasma, and the upper section of the syringe is platelet-poor plasma.
S3, placing the inner and outer double-injector structure into a freezing sleeve, packaging according to the aseptic packaging requirement, then placing the double-injector structure into a freezing chamber of 0-20 ℃ for 30 minutes after carrying out sterilization treatment, and taking out the double-injector. Taking another sterilized blood taking needle with a luer connector needle base, taking down the plugging spiral cover of the double syringes, and installing the needle base connector of the blood taking needle on the outer needle base of the outer syringe.
Conventional disinfection, the blood taking needle is used for puncturing the vein, after blood returns, the syringe of the inner syringe is pulled, and the blood flows into the outer syringe; after blood collection is finished, taking down a luer connector needle seat of a blood collection needle, installing a plugging spiral cover on an outer needle seat of an outer syringe, putting the double syringes into a freezing sleeve again, putting the freezing sleeve and the freezing sleeve into a horizontal centrifuge, balancing the centrifuge, setting a centrifugal force of 700G for 8 minutes, taking out the double syringes after centrifugation, pulling a push-pull rod of the syringes, sucking platelet-rich plasma of a faint yellow liquid part in the outer syringe into the inner syringe, taking another plugging spiral cover to seal the needle seat of the inner syringe, and standing at room temperature (25-30 ℃) for 60 minutes, wherein fibrinogen in the syringes is converted into fibrin at the moment, and the plasma is changed into jelly-shaped gel.
The utility model provides a platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation through improvement, compared with the prior art, the platelet-rich plasma collecting and separating device has the following improvement and advantages:
(1) the inner injector is arranged in the outer injector, the piston assembly is arranged between the inner injector and the outer injector, the piston assembly is provided with the rotation stopping support and the liquid inlet hole, and the injector push-pull rod is arranged in the inner injector, so that the platelet-rich plasma centrifuged in the outer injector is easily extracted into the inner injector, and the platelet-rich plasma is conveniently separated.
(2) The utility model utilizes the frozen water filled in the interlayer of the freezing sleeve, so that the blood does not need to be added with coagulant during centrifugation, the coagulation factor can not be activated at low temperature, and the platelet-rich plasma at the separation part is further purified.
(3) The utility model makes use of the blood to be centrifuged for a plurality of times, so that the content of the platelet-rich plasma in the separated plasma is higher, and the utility model has convenient separation of the platelet-rich plasma and short separation time, thereby realizing the effects of high separation quality and high separation efficiency of the platelet-rich plasma.
(4) According to the utility model, the hollow groove on the fixed anti-rotation frame is matched with the protrusion on the inner wall of the top of the outer injector, so that when the inner injector rotates, the piston and the fixed anti-rotation frame cannot rotate, and the inner injector and the piston are more conveniently separated.
Drawings
The utility model is further explained below with reference to the figures and examples:
FIG. 1 is a schematic view of the overall structure of the present invention;
FIG. 2 is a schematic view of the outer syringe configuration of the present invention;
FIG. 3 is a schematic diagram of the internal injector configuration of the present invention;
FIG. 4 is a schematic view of the inner piston structure of the present invention;
FIG. 5 is a schematic view of the fixed anti-rotation frame of the present invention;
FIG. 6 is a schematic view of the closure cap of the present invention;
FIG. 7 is a schematic view of the freeze sleeve construction of the present invention;
fig. 8 is a flow chart of a method of the present invention.
Description of reference numerals:
the injection device comprises an outer injector 1, an inner injector 2, an injector push-pull rod 3, a freezing sleeve 4, an outer sleeve 5, an inner sleeve 6, an interlayer 7, a piston assembly 13, a fixed anti-rotation frame 14, a protrusion 15, a connector 16, a hollow groove 18, a liquid inlet hole 20, an inner needle seat 21, a retaining ring 22, a pull ring 23, a push-pull handle 24, an inner piston 25, an outer needle seat 26, a plugging screw cap 27 and a plug rod 28.
Detailed Description
The present invention will be described in detail below with reference to fig. 1 to 8, and the technical solutions in the embodiments of the present invention will be clearly and completely described, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
A platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation comprises an outer injector 1, wherein an inner injector 2 is inserted into the outer injector 1, a piston assembly 13 is arranged at the bottom of the inner injector 2, the piston assembly 13 is positioned inside the outer injector 1, a fixed anti-rotation frame 14 is integrally formed at the top of the piston assembly 13, the fixed anti-rotation frame 14 is positioned between the outer injector 1 and the inner injector 2, an injector push-pull rod 3 is inserted into the inner injector 2, a push-pull handle 24 is integrally formed on the outer wall of the top of the injector push-pull rod 3, an inner piston 25 is connected to the bottom end of the injector push-pull rod 3 through threads, and the inner piston 25 is positioned inside the inner injector 2;
fixed anti-rotation frame 14 is cavity sleeve tube column structure, fixed anti-rotation frame 14 marginal portion opens there is fretwork groove 18, fixed anti-rotation frame 14 remains two-sided stand, the lower extreme of piston assembly 13 is planar structure, it has feed liquor hole 20 to open in the middle of the piston assembly 13, 20 top integrated into one piece in feed liquor hole of piston assembly 13 have the connector 16 of external screw thread structure, the bottom outer wall integrated into one piece of interior syringe 2 has interior needle file 21, 16 threaded connection of connector is inside interior needle file 21, outer syringe 1 is linked together through feed liquor hole 20 with interior syringe 2.
Further, an outer needle seat 26 is integrally formed on the bottom outer wall of the outer syringe 1, and the freezing sleeve 4 is sleeved outside the outer syringe 1.
Further, the top inner wall of the outer injector 1 is integrally formed with two protrusions 15, and the two protrusions 15 are matched with the hollow groove 18.
Further, the bottom of the outer needle base 26 is sleeved with a plugging screw cap 27, the inner wall of the bottom of the plugging screw cap 27 is integrally formed with a plug rod 28, the plug rod 28 is connected to the inside of the outer needle base 26 in a threaded manner, and the plug rod 28 is matched with the inner needle base 21.
Further, freezing sleeve 4 includes outer tube 5 and interior sleeve pipe 6, be provided with water storage chamber intermediate layer 7 between outer tube 5 and the interior sleeve pipe 6.
Furthermore, a certain amount of purified water is filled in the interlayer 7, the inner pipe and the outer pipe are sealed by adopting the modes of ultrasonic welding, adhesive plugging and the like after the purified water is filled in, and the low temperature can be kept for a certain time after the inner pipe and the outer pipe are frozen.
Further, a retaining ring 22 is integrally formed on the top outer wall of the outer syringe 1, and a pull ring 23 is integrally formed on the top outer wall of the inner syringe 2.
A method for preparing platelet rich plasma by physical freezing anticoagulation specifically comprises the following steps:
s1, freezing, namely sleeving a freezing sleeve 4 at the bottom of an outer injector 1, packaging a collecting and separating device under an aseptic condition, then carrying out sterilization treatment, and taking out the collecting and separating device after a freezing chamber is used for a period of time;
s2, centrifuging, namely taking a sterilized blood taking needle with a luer connector needle seat, taking down a blocking rotary cover 27 on an outer needle seat 26 of an outer injector 1, mounting a needle seat connector of the blood taking needle on the outer needle seat 26, carrying out conventional disinfection on the arm of a human body, puncturing a vein blood vessel by using the blood taking needle, pulling an inner injector 2 after blood return is seen, enabling the blood to flow into the outer injector 1, taking down the luer connector needle seat of the blood taking needle after blood taking, connecting a plug rod 28 in the blocking rotary cover 27 in the outer needle seat 26 in a threaded manner, putting the outer injector 1 into a freezing sleeve 4 again, putting the freezing sleeve 4 into a horizontal centrifuge, balancing the centrifuge and centrifuging the blood;
s3, separating, namely, downwards arranging the end of a sealing screw cap 27 of the blood sampling device after centrifugation, wherein the internal blood of the external injector 1 is divided into two layers, the lower red part is mainly red blood cells, the upper yellowish part is plasma rich in platelets, pulling the injector push-pull rod 3 through the push-pull handle 24, sucking the platelet-rich plasma of the yellowish liquid part in the external injector 1 into the internal injector 2, then upwards pulling the injector push-pull rod 3 and the internal injector 2, enabling the piston assembly 13 to upwards move, enabling the hollow groove 18 of the fixed rotation-preventing frame 14 to be matched with the bulge 15 on the inner wall of the external injector 1, rotating the internal injector 2, enabling the limiting support to be in threaded separation with the internal injector 2 through the blockage of the bulge 15, and taking another sealing screw cap 27 to be in threaded connection with the internal needle seat 21;
s4, secondary centrifugation, namely putting the inner injector 2 into the freezing sleeve 4 again, then putting the inner injector and the freezing sleeve together into a horizontal centrifuge, balancing the centrifuge, centrifuging the platelet-rich plasma, taking out the inner injector 2 after the centrifugation is finished, wherein the lower section of the inner injector 2 close to the inner needle base 21 is high-concentration platelets, and the upper section is platelet-poor plasma;
s5, packaging and maintaining, wherein the push-pull rod 3 of the injector is pushed by the push handle, so that the high-concentration platelets and the platelet plasma are respectively injected into different containers for storage.
Further, in the step S1, the temperature of the freezing chamber is 0-20 ℃, and the freezing time is 25-35 minutes.
Further, in the S2, the centrifugal force of the horizontal centrifuge is set to 650-750G, and the centrifugation time is 7-9 minutes, and in the S4, the centrifugal force of the horizontal centrifuge is set to 300-500G, and the centrifugation time is 3-6 minutes.
Example one
A method for preparing platelet rich plasma by physical freezing anticoagulation specifically comprises the following steps:
s1, freezing, namely sleeving a freezing sleeve 4 at the bottom of an outer injector 1, packaging a collecting and separating device under an aseptic condition, then carrying out sterilization treatment, taking out the collecting and separating device after a freezing chamber is used for a period of time, wherein the temperature of the freezing chamber is 20 ℃, and the freezing time is 30 minutes;
s2, centrifuging, namely taking a sterilized blood taking needle with a luer connector needle seat, taking down a blocking rotary cover 27 on an outer needle seat 26 of an outer syringe 1, mounting a needle seat connector of the blood taking needle on the outer needle seat 26, carrying out conventional disinfection on the arm of a human body, puncturing a vein blood vessel by using the blood taking needle, pulling an inner syringe 2 after blood return is seen, enabling the blood to flow into the outer syringe 1, taking down the luer connector needle seat of the blood taking needle after blood taking is finished, connecting a plug rod 28 in the blocking rotary cover 27 in the outer needle seat 26 in a threaded manner, putting the outer syringe 1 into a freezing sleeve 4 again, putting the freezing sleeve 4 into a horizontal centrifuge together with the whole freezing sleeve 4, balancing the centrifuge, centrifuging the blood, setting the centrifugal force of the horizontal centrifuge to be 700G, and centrifuging for 8 minutes;
s3, separating, namely, downwards arranging the end of a sealing screw cap 27 of the blood sampling device after centrifugation, wherein the internal blood of the external injector 1 is seen to be divided into two layers, the lower red part is mainly red blood cells, the upper yellowish part is plasma rich in platelets, and pulls the syringe push-pull rod 3 through the push-pull handle 24 to suck platelet-rich plasma in the yellowish liquid portion of the outer syringe 1 into the inner syringe 2, and then pulls the syringe push-pull rod 3 and the inner syringe 2 upward, causing the piston assembly 13 to move upward, and the hollow-out grooves 18 of the fixed anti-rotation rack 14 are engaged with the protrusions 15 of the inner wall of the outer syringe 1, at which time the inner syringe 2 is rotated, the limit bracket is separated from the inner syringe 2 by the blocking of the bulge 15 through screw thread, another plugging screw cap 27 is taken to be connected with the inner needle base 21 through screw thread, and the inner part of the inner syringe 2 is the required platelet-rich plasma.
Example two
A method for preparing platelet rich plasma by physical freezing anticoagulation specifically comprises the following steps:
s1, freezing, namely sleeving a freezing sleeve 4 at the bottom of an outer injector 1, packaging a collecting and separating device under an aseptic condition, then carrying out sterilization treatment, taking out the collecting and separating device after a freezing chamber is used for a period of time, wherein the temperature of the freezing chamber is 20 ℃, and the freezing time is 30 minutes;
s2, centrifuging, namely taking a sterilized blood taking needle with a luer connector needle seat, taking down a blocking rotary cover 27 on an outer needle seat 26 of an outer syringe 1, mounting a needle seat connector of the blood taking needle on the outer needle seat 26, carrying out conventional disinfection on the arm of a human body, puncturing a vein blood vessel by using the blood taking needle, pulling an inner syringe 2 after blood return is seen, enabling the blood to flow into the outer syringe 1, taking down the luer connector needle seat of the blood taking needle after blood taking is finished, connecting a plug rod 28 in the blocking rotary cover 27 in the outer needle seat 26 in a threaded manner, putting the outer syringe 1 into a freezing sleeve 4 again, putting the freezing sleeve 4 into a horizontal centrifuge together with the whole freezing sleeve 4, balancing the centrifuge, centrifuging the blood, setting the centrifugal force of the horizontal centrifuge to be 700G, and centrifuging for 8 minutes;
s3, separating, namely, downwards arranging the end of a sealing screw cap 27 of the blood sampling device after centrifugation, wherein the internal blood of the external injector 1 is divided into two layers, the lower red part is mainly red blood cells, the upper yellowish part is plasma rich in platelets, pulling the injector push-pull rod 3 through the push-pull handle 24, sucking the platelet-rich plasma of the yellowish liquid part in the external injector 1 into the internal injector 2, then upwards pulling the injector push-pull rod 3 and the internal injector 2, enabling the piston assembly 13 to upwards move, enabling the hollow groove 18 of the fixed rotation-preventing frame 14 to be matched with the bulge 15 on the inner wall of the external injector 1, rotating the internal injector 2, enabling the limiting support to be in threaded separation with the internal injector 2 through the blockage of the bulge 15, and taking another sealing screw cap 27 to be in threaded connection with the internal needle seat 21;
s4, secondary centrifugation, namely putting the inner injector 2 into the freezing sleeve 4 again, then putting the inner injector and the freezing sleeve together into a horizontal centrifuge, balancing the centrifuge, centrifuging the platelet-rich plasma, taking out the inner injector 2 after the centrifugation is finished, wherein the lower section of the inner needle base 21 close to the inner injector 2 is high-concentration platelets, the upper section of the inner needle base is platelet-poor plasma, the centrifugal force of the horizontal centrifuge is set to be 300G, and the centrifugation time is 5 minutes;
s5, packaging and maintaining, wherein the push-pull rod 3 of the injector is pushed by the push handle, so that the high-concentration platelets and the platelet plasma are respectively injected into different containers for storage.
EXAMPLE III
A preparation method of platelet rich plasma by physical freezing anticoagulation specifically comprises the following steps:
s1, freezing, namely sleeving a freezing sleeve 4 at the bottom of an outer injector 1, packaging a collecting and separating device under an aseptic condition, then carrying out sterilization treatment, taking out the collecting and separating device after a freezing chamber is used for a period of time, wherein the temperature of the freezing chamber is 20 ℃, and the freezing time is 30 minutes;
s2, centrifuging, namely taking a sterilized blood taking needle with a luer connector needle seat, taking down a blocking rotary cover 27 on an outer needle seat 26 of an outer syringe 1, mounting a needle seat connector of the blood taking needle on the outer needle seat 26, carrying out conventional disinfection on the arm of a human body, puncturing a vein blood vessel by using the blood taking needle, pulling an inner syringe 2 after blood return is seen, enabling the blood to flow into the outer syringe 1, taking down the luer connector needle seat of the blood taking needle after blood taking is finished, connecting a plug rod 28 in the blocking rotary cover 27 in the outer needle seat 26 in a threaded manner, putting the outer syringe 1 into a freezing sleeve 4 again, putting the freezing sleeve 4 into a horizontal centrifuge together with the whole freezing sleeve 4, balancing the centrifuge, centrifuging the blood, setting the centrifugal force of the horizontal centrifuge to be 700G, and centrifuging for 8 minutes;
s3, separating, namely, downwards arranging the end of a sealing screw cap 27 of the blood sampling device after centrifugation, wherein the blood in the outer injector 1 is visible to be divided into two layers, the red part at the lower layer is mainly red blood cells, the light yellow part at the upper layer is plasma rich in blood platelets, pulling a syringe push-pull rod 3 through a push-pull handle 24, sucking the plasma rich in blood platelets of the light yellow liquid part in the outer injector 1 into the inner injector 2, then upwards pulling the syringe push-pull rod 3 and the inner injector 2 to enable a piston assembly 13 to upwards move, enabling a hollow groove 18 of a fixed rotation-preventing frame 14 to be matched with a bulge 15 on the inner wall of the outer injector 1, rotating the inner injector 2 to enable a limiting support to be separated from the inner injector 2 through the blockage of the bulge 15 in a threaded mode, taking another sealing screw cap 27 to be connected with an inner needle base 21 in a threaded mode, and enabling the inner injector 2 to be rich in needed blood platelets at the moment, the inner syringe 2 is left at room temperature for 60 minutes, at which time fibrinogen in the inner syringe 2 is converted to fibrin and the plasma becomes a jelly-like gel.
The number of centrifugation times used in example one, example two, and example three were different, and the other parameters were the same, and observation of the finally obtained platelet-rich plasma under a microscope showed that the concentration of platelets contained in example two was the highest, and therefore, the effect was the best in example two.
The working principle is as follows: s1, freezing, namely sleeving a freezing sleeve 4 at the bottom of an outer injector 1, packaging a collecting and separating device under an aseptic condition, then carrying out sterilization treatment, and taking out the collecting and separating device after a freezing chamber is used for a period of time; s2, centrifuging, namely taking a sterilized blood taking needle with a luer connector needle seat, taking down a blocking rotary cover 27 on an outer needle seat 26 of an outer injector 1, mounting a needle seat connector of the blood taking needle on the outer needle seat 26, carrying out conventional disinfection on the arm of a human body, puncturing a vein blood vessel by using the blood taking needle, pulling an inner injector 2 after blood return is seen, enabling the blood to flow into the outer injector 1, taking down the luer connector needle seat of the blood taking needle after blood taking, connecting a plug rod 28 in the blocking rotary cover 27 in the outer needle seat 26 in a threaded manner, putting the outer injector 1 into a freezing sleeve 4 again, putting the freezing sleeve 4 into a horizontal centrifuge, balancing the centrifuge and centrifuging the blood; s3, separating, namely, downwards arranging the end of a sealing screw cap 27 of the blood sampling device after centrifugation, wherein the internal blood of the external injector 1 is divided into two layers, the lower red part is mainly red blood cells, the upper yellowish part is plasma rich in platelets, pulling the injector push-pull rod 3 through the push-pull handle 24, sucking the platelet-rich plasma of the yellowish liquid part in the external injector 1 into the internal injector 2, then upwards pulling the injector push-pull rod 3 and the internal injector 2, enabling the piston assembly 13 to upwards move, enabling the hollow groove 18 of the fixed rotation-preventing frame 14 to be matched with the bulge 15 on the inner wall of the external injector 1, rotating the internal injector 2, enabling the limiting support to be in threaded separation with the internal injector 2 through the blockage of the bulge 15, and taking another sealing screw cap 27 to be in threaded connection with the internal needle seat 21; s4, secondary centrifugation, namely putting the inner injector 2 into the freezing sleeve 4 again, then putting the inner injector and the freezing sleeve together into a horizontal centrifuge, balancing the centrifuge, centrifuging the platelet-rich plasma, taking out the inner injector 2 after the centrifugation is finished, wherein the lower section of the inner injector 2 close to the inner needle base 21 is high-concentration platelets, and the upper section is platelet-poor plasma; s5, packaging and maintaining, wherein the push-pull rod 3 of the injector is pushed by the push handle, so that the high-concentration platelets and the platelet plasma are respectively injected into different containers for storage.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the utility model. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (6)
1. The utility model provides an adopt platelet rich plasma collection separator of physical freezing anticoagulation which characterized in that: including outer syringe (1), the inside grafting of outer syringe (1) has interior syringe (2), the bottom of interior syringe (2) is provided with piston assembly (13), piston assembly (13) are located the inside of outer syringe (1), piston assembly (13) top integrated into one piece has fixed anti-rotation frame (14), fixed anti-rotation frame (14) are located between outer syringe (1) and interior syringe (2).
2. The platelet rich plasma collection and separation device using physical freezing anticoagulation according to claim 1, characterized in that: fixed anti-rotation frame (14) are cavity sleeve tube column structure, open fixed anti-rotation frame (14) edge part has fretwork groove (18), fixed anti-rotation frame (14) remain two-sided stand, the lower extreme of piston assembly (13) is planar structure, it has feed liquor hole (20) to open in the middle of piston assembly (13) lower part, feed liquor hole (20) top integrated into one piece of piston assembly (13) has connector (16) of external screw thread structure.
3. The platelet rich plasma collection and separation device using physical freezing anticoagulation according to claim 1, characterized in that: the outer wall of the outer part of the outer injector (1) is sleeved with a freezing sleeve (4) with an interlayer.
4. The platelet rich plasma collection and separation device using physical freeze anticoagulation according to claim 1, characterized in that: the top inner wall of the outer injector (1) is integrally formed with two protrusions (15), and the two protrusions (15) are matched with the hollow groove (18).
5. The platelet rich plasma collection and separation device using physical freezing anticoagulation according to claim 1, characterized in that: outer syringe (1)'s bottom outer wall integrated into one piece has outer needle file (26), shutoff spiral cover (27) have been cup jointed to the bottom of outer needle file (26), the bottom inner wall integrated into one piece of shutoff spiral cover (27) has gag lever post (28), gag lever post (28) threaded connection is in the inside of outer needle file (26), gag lever post (28) and interior needle file (21) looks adaptation.
6. The platelet rich plasma collection and separation device using physical freezing anticoagulation according to claim 3, characterized in that: freezing sleeve pipe (4) are including outer tube (5) and interior sleeve pipe (6), be provided with water storage chamber intermediate layer (7) between outer tube (5) and interior sleeve pipe (6).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202121875783.XU CN216497618U (en) | 2021-08-12 | 2021-08-12 | Platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202121875783.XU CN216497618U (en) | 2021-08-12 | 2021-08-12 | Platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN216497618U true CN216497618U (en) | 2022-05-13 |
Family
ID=81515562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202121875783.XU Active CN216497618U (en) | 2021-08-12 | 2021-08-12 | Platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN216497618U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113456910A (en) * | 2021-08-12 | 2021-10-01 | 起源细胞技术(滁州)有限公司 | Platelet-rich plasma collecting and separating device adopting physical (freezing) anticoagulation |
-
2021
- 2021-08-12 CN CN202121875783.XU patent/CN216497618U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113456910A (en) * | 2021-08-12 | 2021-10-01 | 起源细胞技术(滁州)有限公司 | Platelet-rich plasma collecting and separating device adopting physical (freezing) anticoagulation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113456910A (en) | Platelet-rich plasma collecting and separating device adopting physical (freezing) anticoagulation | |
| KR101194044B1 (en) | Single unit kit for separating blood and concentrating prp and method for extracting prp using thereof | |
| US8727133B2 (en) | Method for the preparation of at least one compound from blood, and extraction device for use in the execution of said method | |
| EP2823832B1 (en) | Component separator | |
| KR20110009651A (en) | A blood separating vial, a blood concentrating vial for extracting platelet rich plasma and a method for extracting prp using the same | |
| KR101406574B1 (en) | Apparatus for separating blood | |
| CN216497618U (en) | Platelet-rich plasma collecting and separating device adopting physical freezing anticoagulation | |
| CN103212125A (en) | Method and special equipment for rapidly extracting platelet-rich high-concentration blood plasma | |
| CN106310720A (en) | Platelet rich plasma separator | |
| CN210935419U (en) | Platelet-rich plasma centrifugal device | |
| CN213217058U (en) | Leukocyte-poor platelet-rich plasma (PRP) preparation set | |
| CN110614169A (en) | Special centrifugal tube assembly for preparing platelet-rich plasma and application method thereof | |
| WO2012121452A1 (en) | Blood separating and concentrating container | |
| CN109893884A (en) | A kind of PRP separation collector and its application method | |
| CN203169690U (en) | Special equipment for quickly extracting platelet-rich and high-concentration plasma | |
| AU2016359598A1 (en) | Methods and apparatus for separating fluid components | |
| CN214439191U (en) | Device for preparing injection type autologous i-PRF | |
| CN1583213A (en) | Apparatus for preparing thrombocyte enriched blood plasma and preparing method thereof | |
| CN212702463U (en) | Platelet-rich plasma centrifugal device | |
| CN211160246U (en) | Special centrifugal tube subassembly of rich platelet plasma preparation | |
| CN114452684A (en) | Platelet-rich plasma extraction and separation kit and extraction method | |
| WO2007141255A1 (en) | Improved disposable device for centrifuging and treating a fluid biological material | |
| CN209422595U (en) | Detachable piston type acquisition separation injecting medicinal platelet rich plasma preparation facilities | |
| CN110064230A (en) | A kind of platelet rich plasma acquisition separation vessel | |
| CN216703068U (en) | Combined and detachable platelet-rich plasma preparation device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |